Moving stem cells to the clinic: Potential and limitations for brain repair

Neuron

Volumn 86, Issue 1, 2015, Pages 187-206

  Steinbeck, Julius A ^a   Studer, Lorenz ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; DOPAMINE; NEUROTRANSMITTER;

BRAIN DEPTH STIMULATION; CELL FUNCTION; CELL THERAPY; CELLS BY BODY ANATOMY; DRUG EFFICACY; HUMAN; IMMUNOMODULATION; IN VIVO STUDY; INTERNEURON; MOTONEURON; NEURAL STEM CELL; NEUROLOGIC DISEASE; OLIGODENDROGLIA; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL; BRAIN DISEASES; PHYSIOLOGY; PROCEDURES; STEM CELL TRANSPLANTATION;

BRAIN DISEASES; HUMANS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84930357522     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2015.03.002     Document Type: Review

References (225)

1. AlDakheel A., Kalia L.V., Lang A.E. Pathogenesis-targeted, disease-modifying therapies in Parkinson disease. Neurotherapeutics 2014, 11:6-23.
2. Amamoto R., Arlotta P. Development-inspired reprogramming of the mammalian central nervous system. Science 2014, 343:1239882.
3. Amariglio N., Hirshberg A., Scheithauer B.W., Cohen Y., Loewenthal R., Trakhtenbrot L., Paz N., Koren-Michowitz M., Waldman D., Leider-Trejo L., et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009, 6:e1000029.
4. Ambasudhan R., Talantova M., Coleman R., Yuan X., Zhu S., Lipton S.A., Ding S. Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. Cell Stem Cell 2011, 9:113-118.
5. Amoroso M.W., Croft G.F., Williams D.J., O'Keeffe S., Carrasco M.A., Davis A.R., Roybon L., Oakley D.H., Maniatis T., Henderson C.E., Wichterle H. Accelerated high-yield generation of limb-innervating motor neurons from human stem cells. J.Neurosci. 2013, 33:574-586.
6. Anderson S.A., Marín O., Horn C., Jennings K., Rubenstein J.L. Distinct cortical migrations from the medial and lateral ganglionic eminences. Development 2001, 128:353-363.
7. Andrews P.W., Cavanagro J., Deans R., Feigel E., Horowitz E., Keating A., Rao M., Turner M., Wilmut I., Yamanaka S. Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells. Nat. Biotechnol. 2014, 32:724-726.
8. Ang C.E., Wernig M. Induced neuronal reprogramming. J.Comp. Neurol. 2014, 522:2877-2886.
9. Aubry L., Bugi A., Lefort N., Rousseau F., Peschanski M., Perrier A.L. Striatal progenitors derived from human ES cells mature into DARPP32 neurons invitro and in quinolinic acid-lesioned rats. Proc. Natl. Acad. Sci. USA 2008, 105:16707-16712.
10. Bachoud-Lévi A.C., Rémy P., Nguyen J.P., Brugières P., Lefaucheur J.P., Bourdet C., Baudic S., Gaura V., Maison P., Haddad B., et al. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 2000, 356:1975-1979.
11. Bachoud-Lévi A.C., Gaura V., Brugières P., Lefaucheur J.P., Boissé M.F., Maison P., Baudic S., Ribeiro M.J., Bourdet C., Remy P., et al. Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. Lancet Neurol. 2006, 5:303-309.
12. Backlund E.O., Granberg P.O., Hamberger B., Knutsson E., Mårtensson A., Sedvall G., Seiger A., Olson L. Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. J.Neurosurg. 1985, 62:169-173.
13. Barker R.A., Barrett J., Mason S.L., Björklund A. Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease. Lancet Neurol. 2013, 12:84-91.
14. Barker R.A., Mason S.L., Harrower T.P., Swain R.A., Ho A.K., Sahakian B.J., Mathur R., Elneil S., Thornton S., Hurrelbrink C., et al. The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease. J.Neurol. Neurosurg. Psychiatry 2013, 84:657-665. NEST-UK collaboration.
15. Battista D., Ganat Y., El Maarouf A., Studer L., Rutishauser U. Enhancement of polysialic acid expression improves function of embryonic stem-derived dopamine neuron grafts in Parkinsonian mice. Stem Cells Transl. Med. 2014, 3:108-113.
16. Berndt A., Lee S.Y., Ramakrishnan C., Deisseroth K. Structure-guided transformation of channelrhodopsin into a light-activated chloride channel. Science 2014, 344:420-424.
17. Boulting G.L., Kiskinis E., Croft G.F., Amoroso M.W., Oakley D.H., Wainger B.J., Williams D.J., Kahler D.J., Yamaki M., Davidow L., et al. A functionally characterized test set of human induced pluripotent stem cells. Nat. Biotechnol. 2011, 29:279-286.
18. Brundin P., Nilsson O.G., Strecker R.E., Lindvall O., Astedt B., Björklund A. Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp. Brain Res. 1986, 65:235-240.
19. Bryson J.B., Machado C.B., Crossley M., Stevenson D., Bros-Facer V., Burrone J., Greensmith L., Lieberam I. Optical control of muscle function by transplantation of stem cell-derived motor neurons in mice. Science 2014, 344:94-97.
20. Busch S.A., Silver J. The role of extracellular matrix in CNS regeneration. Curr. Opin. Neurobiol. 2007, 17:120-127.
21. Caldwell M.A., He X., Wilkie N., Pollack S., Marshall G., Wafford K.A., Svendsen C.N. Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat. Biotechnol. 2001, 19:475-479.
22. Callaway E.M. Transneuronal circuit tracing with neurotropic viruses. Curr. Opin. Neurobiol. 2008, 18:617-623.
23. Cao W., Yang Y., Wang Z., Liu A., Fang L., Wu F., Hong J., Shi Y., Leung S., Dong C., Zhang J.Z. Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease. Immunity 2011, 35:273-284.
24. Cao G., Platisa J., Pieribone V.A., Raccuglia D., Kunst M., Nitabach M.N. Genetically targeted optical electrophysiology in intact neural circuits. Cell 2013, 154:904-913.
25. Caraci F., Bosco P., Leggio G.M., Malaguarnera M., Drago F., Bucolo C., Salomone S. Clinical pharmacology of novel anti-Alzheimer disease modifying medications. Curr. Top. Med. Chem. 2013, 13:1853-1863.
26. Cave J.W., Wang M., Baker H. Adult subventricular zone neural stem cells as a potential source of dopaminergic replacement neurons. Front. Neurosci. 2014, 8:16.
27. Cenci M.A., Kalén P., Mandel R.J., Wictorin K., Björklund A. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum. Neuroscience 1992, 46:943-957.
28. Chambers S.M., Fasano C.A., Papapetrou E.P., Tomishima M., Sadelain M., Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 2009, 27:275-280.
29. Chan C.S., Gertler T.S., Surmeier D.J. A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson's disease. Mov. Disord. 2010, 25(1):S63-S70.
30. Chaudhury D., Walsh J.J., Friedman A.K., Juarez B., Ku S.M., Koo J.W., Ferguson D., Tsai H.C., Pomeranz L., Christoffel D.J., et al. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 2013, 493:532-536.
31. Chen T.W., Wardill T.J., Sun Y., Pulver S.R., Renninger S.L., Baohan A., Schreiter E.R., Kerr R.A., Orger M.B., Jayaraman V., et al. Ultrasensitive fluorescent proteins for imaging neuronal activity. Nature 2013, 499:295-300.
32. Chuong A.S., Miri M.L., Busskamp V., Matthews G.A., Acker L.C., Sørensen A.T., Young A., Klapoetke N.C., Henninger M.A., Kodandaramaiah S.B., et al. Noninvasive optical inhibition with a red-shifted microbial rhodopsin. Nat. Neurosci. 2014, 17:1123-1129.
33. Conti L., Cattaneo E. Neural stem cell systems: physiological players or invitro entities?. Nat. Rev. Neurosci. 2010, 11:176-187.
34. Cooper O., Astradsson A., Hallett P., Robertson H., Mendez I., Isacson O. Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patients. J.Neurol. 2009, 256(Suppl 3):310-316.
35. Cord B.J., Li J., Works M., McConnell S.K., Palmer T., Hynes M.A. Characterization of axon guidance cue sensitivity of human embryonic stem cell-derived dopaminergic neurons. Mol. Cell. Neurosci. 2010, 45:324-334.
36. Crook J.M., Peura T.T., Kravets L., Bosman A.G., Buzzard J.J., Horne R., Hentze H., Dunn N.R., Zweigerdt R., Chua F., et al. The generation ofsix clinical-grade human embryonic stem cell lines. Cell Stem Cell 2007, 1:490-494.
37. Cuenca N., Fernández-Sánchez L., McGill T.J., Lu B., Wang S., Lund R., Huhn S., Capela A. Phagocytosis of photoreceptor outer segments by transplanted human neural stem cells as a neuroprotective mechanism in retinal degeneration. Invest. Ophthalmol. Vis. Sci. 2013, 54:6745-6756.
38. Cummings B.J., Uchida N., Tamaki S.J., Salazar D.L., Hooshmand M., Summers R., Gage F.H., Anderson A.J. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc. Natl. Acad. Sci. USA 2005, 102:14069-14074.
39. Cunningham M., Cho J.H., Leung A., Savvidis G., Ahn S., Moon M., Lee P.K., Han J.J., Azimi N., Kim K.S., et al. hPSC-derived maturing GABAergic interneurons ameliorate seizures and abnormal behavior in epileptic mice. Cell Stem Cell 2014, 15:559-573.
40. Davis-Dusenbery B.N., Williams L.A., Klim J.R., Eggan K. How to make spinal motor neurons. Development 2014, 141:491-501.
41. De la Rossa A., Bellone C., Golding B., Vitali I., Moss J., Toni N., Lüscher C., Jabaudon D. Invivo reprogramming of circuit connectivity in postmitotic neocortical neurons. Nat. Neurosci. 2013, 16:193-200.
42. Dell'Anno M.T., Caiazzo M., Leo D., Dvoretskova E., Medrihan L., Colasante G., Giannelli S., Theka I., Russo G., Mus L., et al. Remote control of induced dopaminergic neurons in parkinsonian rats. J.Clin. Invest. 2014, 124:3215-3229.
43. Delli Carri A., Onorati M., Lelos M.J., Castiglioni V., Faedo A., Menon R., Camnasio S., Vuono R., Spaiardi P., Talpo F., et al. Developmentally coordinated extrinsic signals drive human pluripotent stem cell differentiation toward authentic DARPP-32+ medium-sized spiny neurons. Development 2013, 140:301-312.
44. Deshpande D.M., Kim Y.S., Martinez T., Carmen J., Dike S., Shats I., Rubin L.L., Drummond J., Krishnan C., Hoke A., et al. Recovery from paralysis in adult rats using embryonic stem cells. Ann. Neurol. 2006, 60:32-44.
45. Di Stasi A., Tey S.K., Dotti G., Fujita Y., Kennedy-Nasser A., Martinez C., Straathof K., Liu E., Durett A.G., Grilley B., et al. Inducible apoptosis as a safety switch for adoptive cell therapy. N.Engl. J. Med. 2011, 365:1673-1683.
46. Dimyan M.A., Cohen L.G. Neuroplasticity in the context of motor rehabilitation after stroke. Nat. Rev. Neurol. 2011, 7:76-85.
47. Doi D., Samata B., Katsukawa M., Kikuchi T., Morizane A., Ono Y., Sekiguchi K., Nakagawa M., Parmar M., Takahashi J. Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation. Stem Cell Reports 2014, 2:337-350.
48. Drukker M., Katchman H., Katz G., Even-Tov Friedman S., Shezen E., Hornstein E., Mandelboim O., Reisner Y., Benvenisty N. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 2006, 24:221-229.
49. Duffy B.A., Weitz A.J., Lee J.H. Invivo imaging of transplanted stem cells in the central nervous system. Curr. Opin. Genet. Dev. 2014, 28:83-88.
50. Dunnett S.B., Björklund A., Stenevi U., Iversen S.D. Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. I. Unilateral lesions. Brain Res. 1981, 215:147-161.
51. Dunnett S.B., Hernandez T.D., Summerfield A., Jones G.H., Arbuthnott G. Graft-derived recovery from 6-OHDA lesions: specificity of ventral mesencephalic graft tissues. Exp. Brain Res. 1988, 71:411-424.
52. Durruthy-Durruthy J., Briggs S.F., Awe J., Ramathal C.Y., Karumbayaram S., Lee P.C., Heidmann J.D., Clark A., Karakikes I., Loh K.M., et al. Rapid and efficient conversion of integration-free human induced pluripotent stem cells to GMP-grade culture conditions. PLoS ONE 2014, 9:e94231.
53. Eiraku M., Watanabe K., Matsuo-Takasaki M., Kawada M., Yonemura S., Matsumura M., Wataya T., Nishiyama A., Muguruma K., Sasai Y. Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell 2008, 3:519-532.
54. El Maarouf A., Petridis A.K., Rutishauser U. Use of polysialic acid in repair of the central nervous system. Proc. Natl. Acad. Sci. USA 2006, 103:16989-16994.
55. El Maarouf A., Moyo-Lee Yaw D., Lindhout T., Pearse D.D., Wakarchuk W., Rutishauser U. Enzymatic engineering of polysialic acid on cells invitro and invivo using a purified bacterial polysialyltransferase. J.Biol. Chem. 2012, 287:32770-32779.
56. El Maarouf A., Moyo-Lee Yaw D., Rutishauser U. Improved stem cell-derived motoneuron survival, migration, sprouting and innervation with enhanced expression of polysialic acid. Cell Transplant. 2014, Published online March 3, 2014. 10.3727/096368914X679228.
57. Elkabetz Y., Panagiotakos G., Al Shamy G., Socci N.D., Tabar V., Studer L. Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev. 2008, 22:152-165.
58. Espuny-Camacho I., Michelsen K.A., Gall D., Linaro D., Hasche A., Bonnefont J., Bali C., Orduz D., Bilheu A., Herpoel A., et al. Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits invivo. Neuron 2013, 77:440-456.
59. Fasano C.A., Chambers S.M., Lee G., Tomishima M.J., Studer L. Efficient derivation of functional floor plate tissue from human embryonic stem cells. Cell Stem Cell 2010, 6:336-347.
60. Flax J.D., Aurora S., Yang C., Simonin C., Wills A.M., Billinghurst L.L., Jendoubi M., Sidman R.L., Wolfe J.H., Kim S.U., Snyder E.Y. Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat. Biotechnol. 1998, 16:1033-1039.
61. Flusberg B.A., Nimmerjahn A., Cocker E.D., Mukamel E.A., Barretto R.P., Ko T.H., Burns L.D., Jung J.C., Schnitzer M.J. High-speed, miniaturized fluorescence microscopy in freely moving mice. Nat. Methods 2008, 5:935-938.
62. Fouad K., Schnell L., Bunge M.B., Schwab M.E., Liebscher T., Pearse D.D. Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J.Neurosci. 2005, 25:1169-1178.
63. Frantz S. Embryonic stem cell pioneer Geron exits field, cuts losses. Nat. Biotechnol. 2012, 30:12-13.
64. Freed C.R., Greene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J.Q., et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N.Engl. J. Med. 2001, 344:710-719.
65. Fu X. The immunogenicity of cells derived from induced pluripotent stem cells. Cell. Mol. Immunol. 2014, 11:14-16.
66. Gage F.H., Temple S. Neural stem cells: generating and regenerating the brain. Neuron 2013, 80:588-601.
67. Gaillard A., Prestoz L., Dumartin B., Cantereau A., Morel F., Roger M., Jaber M. Reestablishment of damaged adult motor pathways by grafted embryonic cortical neurons. Nat. Neurosci. 2007, 10:1294-1299.
68. Ganat Y.M., Calder E.L., Kriks S., Nelander J., Tu E.Y., Jia F., Battista D., Harrison N., Parmar M., Tomishima M.J., et al. Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment. J.Clin. Invest. 2012, 122:2928-2939.
69. Garcia I., Huang L., Ung K., Arenkiel B.R. Tracing synaptic connectivity onto embryonic stem cell-derived neurons. Stem Cells 2012, 30:2140-2151.
70. Ghosh K.K., Burns L.D., Cocker E.D., Nimmerjahn A., Ziv Y., Gamal A.E., Schnitzer M.J. Miniaturized integration of a fluorescence microscope. Nat. Methods 2011, 8:871-878.
71. Glass J.D., Boulis N.M., Johe K., Rutkove S.B., Federici T., Polak M., Kelly C., Feldman E.L. Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients. Stem Cells 2012, 30:1144-1151.
72. Glavaski-Joksimovic A., Virag T., Mangatu T.A., McGrogan M., Wang X.S., Bohn M.C. Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease. J.Neurosci. Res. 2010, 88:2669-2681.
73. Goldman S.A., Nedergaard M., Windrem M.S. Glial progenitor cell-based treatment and modeling of neurological disease. Science 2012, 338:491-495.
74. Gradinaru V., Zhang F., Ramakrishnan C., Mattis J., Prakash R., Diester I., Goshen I., Thompson K.R., Deisseroth K. Molecular and cellular approaches for diversifying and extending optogenetics. Cell 2010, 141:154-165.
75. Graf T., Enver T. Forcing cells to change lineages. Nature 2009, 462:587-594.
76. Grealish S., Mattsson B., Draxler P., Björklund A. Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease. Eur. J. Neurosci. 2010, 31:2266-2278.
77. Grealish S., Diguet E., Kirkeby A., Mattsson B., Heuer A., Bramoulle Y., Van Camp N., Perrier A.L., Hantraye P., Björklund A., Parmar M. Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson's disease. Cell Stem Cell 2014, 15:653-665.
78. Grienberger C., Konnerth A. Imaging calcium in neurons. Neuron 2012, 73:862-885.
79. Guo X., Gonzalez M., Stancescu M., Vandenburgh H.H., Hickman J.J. Neuromuscular junction formation between human stem cell-derived motoneurons and human skeletal muscle in a defined system. Biomaterials 2011, 32:9602-9611.
80. Gupta N., Henry R.G., Strober J., Kang S.M., Lim D.A., Bucci M., Caverzasi E., Gaetano L., Mandelli M.L., Ryan T., et al. Neural stem cellengraftment and myelination in the human brain. Sci. Transl. Med. 2012, 4:155ra137.
81. Hefferan M.P., Galik J., Kakinohana O., Sekerkova G., Santucci C., Marsala S., Navarro R., Hruska-Plochan M., Johe K., Feldman E., et al. Human neural stem cell replacement therapy for amyotrophic lateral sclerosis by spinal transplantation. PLoS ONE 2012, 7:e42614.
82. Hochbaum D.R., Zhao Y., Farhi S.L., Klapoetke N., Werley C.A., Kapoor V., Zou P., Kralj J.M., Maclaurin D., Smedemark-Margulies N., et al. All-optical electrophysiology in mammalian neurons using engineered microbial rhodopsins. Nat. Methods 2014, 11:825-833.
83. Horie N., Pereira M.P., Niizuma K., Sun G., Keren-Gill H., Encarnacion A., Shamloo M., Hamilton S.A., Jiang K., Huhn S., et al. Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells 2011, 29:274-285.
84. Hou Z., Zhang Y., Propson N.E., Howden S.E., Chu L.F., Sontheimer E.J., Thomson J.A. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc. Natl. Acad. Sci. USA 2013, 110:15644-15649.
85. Hsu P.D., Lander E.S., Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 2014, 157:1262-1278.
86. Hu B.Y., Du Z.W., Li X.J., Ayala M., Zhang S.C. Human oligodendrocytes from embryonic stem cells: conserved SHH signaling networks and divergent FGF effects. Development 2009, 136:1443-1452.
87. Ikegami T., Nakamura M., Yamane J., Katoh H., Okada S., Iwanami A., Watanabe K., Ishii K., Kato F., Fujita H., et al. Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growth-associated protein-43-positive fibers after rat spinal cord injury. Eur. J. Neurosci. 2005, 22:3036-3046.
88. Jain M., Armstrong R.J., Tyers P., Barker R.A., Rosser A.E. GABAergic immunoreactivity is predominant in neurons derived from expanded human neural precursor cells invitro. Exp. Neurol. 2003, 182:113-123.
89. Johannesson B., Sagi I., Gore A., Paull D., Yamada M., Golan-Lev T., Li Z., LeDuc C., Shen Y., Stern S., et al. Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors. Cell Stem Cell 2014, 15:634-642.
90. Johnson M.A., Weick J.P., Pearce R.A., Zhang S.C. Functional neural development from human embryonic stem cells: accelerated synaptic activity via astrocyte coculture. J.Neurosci. 2007, 27:3069-3077.
91. Karumbayaram S., Novitch B.G., Patterson M., Umbach J.A., Richter L., Lindgren A., Conway A.E., Clark A.T., Goldman S.A., Plath K., et al. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells 2009, 27:806-811.
92. Keirstead H.S., Nistor G., Bernal G., Totoiu M., Cloutier F., Sharp K., Steward O. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J.Neurosci. 2005, 25:4694-4705.
93. Kirkeby A., Grealish S., Wolf D.A., Nelander J., Wood J., Lundblad M., Lindvall O., Parmar M. Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep. 2012, 1:703-714.
94. Kiuru M., Boyer J.L., O'Connor T.P., Crystal R.G. Genetic control of wayward pluripotent stem cells and their progeny after transplantation. Cell Stem Cell 2009, 4:289-300.
95. Klein D., Schmandt T., Muth-Köhne E., Perez-Bouza A., Segschneider M., Gieselmann V., Brüstle O. Embryonic stem cell-based reduction of central nervous system sulfatide storage in an animal model of metachromatic leukodystrophy. Gene Ther. 2006, 13:1686-1695.
96. Koch P., Opitz T., Steinbeck J.A., Ladewig J., Brüstle O. Arosette-type, self-renewing human ES cell-derived neural stem cell with potential for invitro instruction and synaptic integration. Proc. Natl. Acad. Sci. USA 2009, 106:3225-3230.
97. Kokaia Z., Martino G., Schwartz M., Lindvall O. Cross-talk between neural stem cells and immune cells: the key to better brain repair?. Nat. Neurosci. 2012, 15:1078-1087.
98. Kravitz A.V., Freeze B.S., Parker P.R., Kay K., Thwin M.T., Deisseroth K., Kreitzer A.C. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 2010, 466:622-626.
99. Kriks S., Shim J.W., Piao J., Ganat Y.M., Wakeman D.R., Xie Z., Carrillo-Reid L., Auyeung G., Antonacci C., Buch A., et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 2011, 480:547-551.
100. Ladewig J., Koch P., Brüstle O. Auto-attraction of neural precursors and their neuronal progeny impairs neuronal migration. Nat. Neurosci. 2014, 17:24-26.
101. Larson P.S., Starr P.A., Bates G., Tansey L., Richardson R.M., Martin A.J. An optimized system for interventional magnetic resonance imaging-guided stereotactic surgery: preliminary evaluation of targeting accuracy. Neurosurgery 2012, 70(1, Suppl Operative):95-103. discussion 103.
102. Lee H., Shamy G.A., Elkabetz Y., Schofield C.M., Harrsion N.L., Panagiotakos G., Socci N.D., Tabar V., Studer L. Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells 2007, 25:1931-1939.
103. Lee J.H., Durand R., Gradinaru V., Zhang F., Goshen I., Kim D.S., Fenno L.E., Ramakrishnan C., Deisseroth K. Global and local fMRI signals driven by neurons defined optogenetically by type and wiring. Nature 2010, 465:788-792.
104. Lee A.S., Tang C., Rao M.S., Weissman I.L., Wu J.C. Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat. Med. 2013, 19:998-1004.
105. Li X.J., Du Z.W., Zarnowska E.D., Pankratz M., Hansen L.O., Pearce R.A., Zhang S.C. Specification of motoneurons from human embryonic stem cells. Nat. Biotechnol. 2005, 23:215-221.
106. Li T., Steinbeck J.A., Lusardi T., Koch P., Lan J.Q., Wilz A., Segschneider M., Simon R.P., Brustle O., Boison D. Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants. Brain 2007, 130:1276-1288.
107. Li J.Y., Englund E., Widner H., Rehncrona S., Bjorklund A., Lindvall O., Brundin P. Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease. Mov. Disord. 2010, 25:1091-1096.
108. Lindvall O., Rehncrona S., Brundin P., Gustavii B., Astedt B., Widner H., Lindholm T., Björklund A., Leenders K.L., Rothwell J.C., et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch. Neurol. 1989, 46:615-631.
109. Lindvall O., Brundin P., Widner H., Rehncrona S., Gustavii B., Frackowiak R., Leenders K.L., Sawle G., Rothwell J.C., Marsden C.D., et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990, 247:574-577.
110. Liu Y., Weick J.P., Liu H., Krencik R., Zhang X., Ma L., Zhou G.M., Ayala M., Zhang S.C. Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits. Nat. Biotechnol. 2013, 31:440-447.
111. Lu B., Malcuit C., Wang S., Girman S., Francis P., Lemieux L., Lanza R., Lund R. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 2009, 27:2126-2135.
112. Lu P., Wang Y., Graham L., McHale K., Gao M., Wu D., Brock J., Blesch A., Rosenzweig E.S., Havton L.A., et al. Long-distance growth and connectivity of neural stem cells after severe spinal cord injury. Cell 2012, 150:1264-1273.
113. Lu P., Kadoya K., Tuszynski M.H. Axonal growth and connectivity from neural stem cell grafts in models of spinal cord injury. Curr. Opin. Neurobiol. 2014, 27:103-109.
114. Lu P., Woodruff G., Wang Y., Graham L., Hunt M., Wu D., Boehle E., Ahmad R., Poplawski G., Brock J., et al. Long-distance axonal growth from human induced pluripotent stem cells after spinal cord injury. Neuron 2014, 83:789-796.
115. Lui J.H., Hansen D.V., Kriegstein A.R. Development and evolution of the human neocortex. Cell 2011, 146:18-36.
116. Ma Y., Tang C., Chaly T., Greene P., Breeze R., Fahn S., Freed C., Dhawan V., Eidelberg D. Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes. J.Nucl. Med. 2010, 51:7-15.
117. Ma L., Hu B., Liu Y., Vermilyea S.C., Liu H., Gao L., Sun Y., Zhang X., Zhang S.C. Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice. Cell Stem Cell 2012, 10:455-464.
118. Ma H., Morey R., O'Neil R.C., He Y., Daughtry B., Schultz M.D., Hariharan M., Nery J.R., Castanon R., Sabatini K., et al. Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature 2014, 511:177-183.
119. Madrazo I., Drucker-Colín R., Díaz V., Martínez-Mata J., Torres C., Becerril J.J. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N.Engl. J. Med. 1987, 316:831-834.
120. Mali P., Yang L., Esvelt K.M., Aach J., Guell M., DiCarlo J.E., Norville J.E., Church G.M. RNA-guided human genome engineering via Cas9. Science 2013, 339:823-826.
121. Maroof A.M., Keros S., Tyson J.A., Ying S.W., Ganat Y.M., Merkle F.T., Liu B., Goulburn A., Stanley E.G., Elefanty A.G., et al. Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells. Cell Stem Cell 2013, 12:559-572.
122. Martínez-Cerdeño V., Noctor S.C., Espinosa A., Ariza J., Parker P., Orasji S., Daadi M.M., Bankiewicz K., Alvarez-Buylla A., Kriegstein A.R. Embryonic MGE precursor cells grafted into adult rat striatum integrate and ameliorate motor symptoms in 6-OHDA-lesioned rats. Cell Stem Cell 2010, 6:238-250.
123. Maskos U., Kissa K., St Cloment C., BrÛlet P. Retrograde trans-synaptic transfer of green fluorescent protein allows the genetic mapping of neuronal circuits in transgenic mice. Proc. Natl. Acad. Sci. USA 2002, 99:10120-10125.
124. Maury Y., Come J., Piskorowski R.A., Salah-Mohellibi N., Chevaleyre V., Peschanski M., Martinat C., Nedelec S. Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes. Nat. Biotechnol. 2015, 33:89-96.
125. Mazzoni E.O., Mahony S., Peljto M., Patel T., Thornton S.R., McCuine S., Reeder C., Boyer L.A., Young R.A., Gifford D.K., Wichterle H. Saltatory remodeling of Hox chromatin in response to rostrocaudal patterning signals. Nat. Neurosci. 2013, 16:1191-1198.
126. McBride J.L., Behrstock S.P., Chen E.Y., Jakel R.J., Siegel I., Svendsen C.N., Kordower J.H. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. J.Comp. Neurol. 2004, 475:211-219.
127. McGill T.J., Cottam B., Lu B., Wang S., Girman S., Tian C., Huhn S.L., Lund R.D., Capela A. Transplantation of human central nervous system stem cells-neuroprotection in retinal degeneration. Eur. J. Neurosci. 2012, 35:468-477.
128. Moon L.D., Asher R.A., Rhodes K.E., Fawcett J.W. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat. Neurosci. 2001, 4:465-466.
129. Morris S.A., Cahan P., Li H., Zhao A.M., San Roman A.K., Shivdasani R.A., Collins J.J., Daley G.Q. Dissecting engineered cell types and enhancing cell fate conversion via CellNet. Cell 2014, 158:889-902.
130. Muldoon L.L., Alvarez J.I., Begley D.J., Boado R.J., Del Zoppo G.J., Doolittle N.D., Engelhardt B., Hallenbeck J.M., Lonser R.R., Ohlfest J.R., et al. Immunologic privilege in the central nervous system and the blood-brain barrier. J.Cereb. Blood Flow Metab. 2013, 33:13-21.
131. Naka-Kaneda H., Nakamura S., Igarashi M., Aoi H., Kanki H., Tsuyama J., Tsutsumi S., Aburatani H., Shimazaki T., Okano H. The miR-17/106-p38 axis is a key regulator of the neurogenic-to-gliogenic transition in developing neural stem/progenitor cells. Proc. Natl. Acad. Sci. USA 2014, 111:1604-1609.
132. Närvä E., Autio R., Rahkonen N., Kong L., Harrison N., Kitsberg D., Borghese L., Itskovitz-Eldor J., Rasool O., Dvorak P., et al. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat. Biotechnol. 2010, 28:371-377.
133. Nestor M.W., Jacob S., Sun B., Pre D., Sproul A.A., Hong S.I., Woodard C., Zimmer M., Chinchalongporn V., Arancio O., Noggle S.A. Characterization of a subpopulation of developing cortical interneurons from human iPSCs within serum free embryoid bodies. Am. J. Physiol. Cell Physiol. 2014, 308:C209-C219.
134. Nicholas C.R., Chen J., Tang Y., Southwell D.G., Chalmers N., Vogt D., Arnold C.M., Chen Y.J., Stanley E.G., Elefanty A.G., et al. Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development. Cell Stem Cell 2013, 12:573-586.
135. Niu W., Zang T., Zou Y., Fang S., Smith D.K., Bachoo R., Zhang C.L. Invivo reprogramming of astrocytes to neuroblasts in the adult brain. Nat. Cell Biol. 2013, 15:1164-1175.
136. Numasawa-Kuroiwa Y., Okada Y., Shibata S., Kishi N., Akamatsu W., Shoji M., Nakanishi A., Oyama M., Osaka H., Inoue K., et al. Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes. Stem Cell Reports 2014, 2:648-661.
137. Nunes M.C., Roy N.S., Keyoung H.M., Goodman R.R., McKhann G., Jiang L., Kang J., Nedergaard M., Goldman S.A. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat. Med. 2003, 9:439-447.
138. Olanow C.W., Goetz C.G., Kordower J.H., Stoessl A.J., Sossi V., Brin M.F., Shannon K.M., Nauert G.M., Perl D.P., Godbold J., Freeman T.B. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 2003, 54:403-414.
139. Orive G., Anitua E., Pedraz J.L., Emerich D.F. Biomaterials for promoting brain protection, repair and regeneration. Nat. Rev. Neurosci. 2009, 10:682-692.
140. Pang Z.P., Yang N., Vierbuchen T., Ostermeier A., Fuentes D.R., Yang T.Q., Citri A., Sebastiano V., Marro S., Südhof T.C., Wernig M. Induction of human neuronal cells by defined transcription factors. Nature 2011, 476:220-223.
141. Panman L., Papathanou M., Laguna A., Oosterveen T., Volakakis N., Acampora D., Kurtsdotter I., Yoshitake T., Kehr J., Joodmardi E., et al. Sox6 and Otx2 control the specification of substantia nigra and ventral tegmental area dopamine neurons. Cell Rep. 2014, 8:1018-1025.
142. Papapetrou E.P., Lee G., Malani N., Setty M., Riviere I., Tirunagari L.M., Kadota K., Roth S.L., Giardina P., Viale A., et al. Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells. Nat. Biotechnol. 2011, 29:73-78.
143. Park K.I., Teng Y.D., Snyder E.Y. The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat. Biotechnol. 2002, 20:1111-1117.
144. Patani R., Hollins A.J., Wishart T.M., Puddifoot C.A., Alvarez S., de Lera A.R., Wyllie D.J., Compston D.A., Pedersen R.A., Gillingwater T.H., et al. Retinoid-independent motor neurogenesis from human embryonic stem cells reveals a medial columnar ground state. Nat. Commun. 2011, 2:214.
145. Patterson M., Gaeta X., Loo K., Edwards M., Smale S., Cinkornpumin J., Xie Y., Listgarten J., Azghadi S., Douglass S.M., et al. let-7 miRNAs can act through notch to regulate human gliogenesis. Stem Cell Reports 2014, 3:758-773.
146. Peljto M., Dasen J.S., Mazzoni E.O., Jessell T.M., Wichterle H. Functional diversity of ESC-derived motor neuron subtypes revealed through intraspinal transplantation. Cell Stem Cell 2010, 7:355-366.
147. Pera M.F. Stem cells: the dark side of induced pluripotency. Nature 2011, 471:46-47.
148. Pera M.F., Andrade J., Houssami S., Reubinoff B., Trounson A., Stanley E.G., Ward-van Oostwaard D., Mummery C. Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin. J.Cell Sci. 2004, 117:1269-1280.
149. Perrier A.L., Tabar V., Barberi T., Rubio M.E., Bruses J., Topf N., Harrison N.L., Studer L. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 2004, 101:12543-12548.
150. Piao J., Major T., Auyeung G., Policarpio E., Menon J., Droms L., Gutin P., Uryu K., Tchieu J., Soulet D., Tabar V. Human embryonic stem cell-derived oligodendrocyte progenitors remyelinate the brain and rescue behavioral deficits following radiation. Cell Stem Cell 2015, 16:198-210.
151. Pina-Crespo J.C., Talantova M., Cho E.G., Soussou W., Dolatabadi N., Ryan S.D., Ambasudhan R., McKercher S., Deisseroth K., Lipton S.A. High-frequency hippocampal oscillations activated by optogenetic stimulation of transplanted human ESC-derived neurons. J.Neurosci. 2012, 32:15837-15842.
152. Pluchino S., Quattrini A., Brambilla E., Gritti A., Salani G., Dina G., Galli R., Del Carro U., Amadio S., Bergami A., et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003, 422:688-694.
153. Pluchino S., Zanotti L., Rossi B., Brambilla E., Ottoboni L., Salani G., Martinello M., Cattalini A., Bergami A., Furlan R., et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 2005, 436:266-271.
154. Pluchino S., Gritti A., Blezer E., Amadio S., Brambilla E., Borsellino G., Cossetti C., Del Carro U., Comi G., 't Hart B., et al. Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates. Ann. Neurol. 2009, 66:343-354.
155. Pluchino S., Zanotti L., Brambilla E., Rovere-Querini P., Capobianco A., Alfaro-Cervello C., Salani G., Cossetti C., Borsellino G., Battistini L., et al. Immune regulatory neural stem/precursor cells protect from central nervous system autoimmunity by restraining dendritic cell function. PLoS ONE 2009, 4:e5959.
156. Politis M., Wu K., Loane C., Quinn N.P., Brooks D.J., Rehncrona S., Bjorklund A., Lindvall O., Piccini P. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci. Transl. Med. 2010, 2:38ra46.
157. Poulin J.F., Zou J., Drouin-Ouellet J., Kim K.Y., Cicchetti F., Awatramani R.B. Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling. Cell Rep. 2014, 9:930-943.
158. Proschel C., Stripay J.L., Shih C.H., Munger J.C., Noble M.D. Delayed transplantation of precursor cell-derived astrocytes provides multiple benefits in a rat model of Parkinsons. EMBO Mol. Med. 2014, 6:504-518.
159. Ramsden C.M., Powner M.B., Carr A.J., Smart M.J., da Cruz L., Coffey P.J. Stem cells in retinal regeneration: past, present and future. Development 2013, 140:2576-2585.
160. Redmond D.E., Bjugstad K.B., Teng Y.D., Ourednik V., Ourednik J., Wakeman D.R., Parsons X.H., Gonzalez R., Blanchard B.C., Kim S.U., et al. Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc. Natl. Acad. Sci. USA 2007, 104:12175-12180.
161. Reubinoff B.E., Itsykson P., Turetsky T., Pera M.F., Reinhartz E., Itzik A., Ben-Hur T. Neural progenitors from human embryonic stem cells. Nat. Biotechnol. 2001, 19:1134-1140.
162. Reuter I., Tai Y.F., Pavese N., Chaudhuri K.R., Mason S., Polkey C.E., Clough C., Brooks D.J., Barker R.A., Piccini P. Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease. J.Neurol. Neurosurg. Psychiatry 2008, 79:948-951.
163. Rogan S.C., Roth B.L. Remote control of neuronal signaling. Pharmacol. Rev. 2011, 63:291-315.
164. Rouaux C., Arlotta P. Direct lineage reprogramming of post-mitotic callosal neurons into corticofugal neurons invivo. Nat. Cell Biol. 2013, 15:214-221.
165. Roy N.S., Cleren C., Singh S.K., Yang L., Beal M.F., Goldman S.A. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med. 2006, 12:1259-1268.
166. Rutishauser U. Polysialic acid in the plasticity of the developing and adult vertebrate nervous system. Nat. Rev. Neurosci. 2008, 9:26-35.
167. Saha B., Jaber M., Gaillard A. Potentials of endogenous neural stem cells in cortical repair. Front. Cell. Neurosci. 2012, 6:14.
168. Salazar D.L., Uchida N., Hamers F.P., Cummings B.J., Anderson A.J. Human neural stem cells differentiate and promote locomotor recovery in an early chronic spinal cord injury NOD-scid mouse model. PLoS ONE 2010, 5:e12272.
169. Sánchez-Pernaute R., Studer L., Bankiewicz K.S., Major E.O., McKay R.D. Invitro generation and transplantation of precursor-derived human dopamine neurons. J.Neurosci. Res. 2001, 65:284-288.
170. Sawinski J., Wallace D.J., Greenberg D.S., Grossmann S., Denk W., Kerr J.N. Visually evoked activity in cortical cells imaged in freely moving animals. Proc. Natl. Acad. Sci. USA 2009, 106:19557-19562.
171. Schwartz S.D., Hubschman J.P., Heilwell G., Franco-Cardenas V., Pan C.K., Ostrick R.M., Mickunas E., Gay R., Klimanskaya I., Lanza R. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 2012, 379:713-720.
172. Schwartz S.D., Regillo C.D., Lam B.L., Eliott D., Rosenfeld P.J., Gregori N.Z., Hubschman J.P., Davis J.L., Heilwell G., Spirn M., et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet 2015, 385:509-516.
173. Selden N.R., Al-Uzri A., Huhn S.L., Koch T.K., Sikora D.M., Nguyen-Driver M.D., Guillaume D.J., Koh J.L., Gultekin S.H., Anderson J.C., et al. Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis. J.Neurosurg. Pediatr. 2013, 11:643-652.
174. Shi Y., Kirwan P., Smith J., Robinson H.P., Livesey F.J. Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses. Nat. Neurosci. 2012, 15:477-486.
175. Singh Roy N., Nakano T., Xuing L., Kang J., Nedergaard M., Goldman S.A. Enhancer-specified GFP-based FACS purification of human spinal motor neurons from embryonic stem cells. Exp. Neurol. 2005, 196:224-234.
176. Smith J.R., Vallier L., Lupo G., Alexander M., Harris W.A., Pedersen R.A. Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm. Dev. Biol. 2008, 313:107-117.
177. Smith B., Carson S., Fu R., McDonagh M., Dana T., Chan B.K.S., Thakurta S., Gibler A. Drug Class Review: Disease-modifying Drugs for Multiple Sclerosis: Final Update 1 Report 2010, Oregon Health & Science University.
178. Sonntag K.C., Pruszak J., Yoshizaki T., van Arensbergen J., Sanchez-Pernaute R., Isacson O. Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells 2007, 25:411-418.
179. Southwell D.G., Nicholas C.R., Basbaum A.I., Stryker M.P., Kriegstein A.R., Rubenstein J.L., Alvarez-Buylla A. Interneurons from embryonic development to cell-based therapy. Science 2014, 344:1240622.
180. Stanzel B.V., Liu Z., Somboonthanakij S., Wongsawad W., Brinken R., Eter N., Corneo B., Holz F.G., Temple S., Stern J.H., Blenkinsop T.A. Human RPE stem cells grown into polarized RPE monolayers on a polyester matrix are maintained after grafting into rabbit subretinal space. Stem Cell Reports 2014, 2:64-77.
181. Steinbeck J.A., Koch P., Derouiche A., Brüstle O. Human embryonic stem cell-derived neurons establish region-specific, long-range projections in the adult brain. Cell. Mol. Life Sci. 2012, 69:461-470.
182. Steinbeck J.A., Choi S.J., Mrejeru A., Ganat Y., Deisseroth K., Sulzer D., Mosharov E.V., Studer L. Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model. Nat. Biotechnol. 2015, 33:204-209.
183. Studer L., Tabar V., McKay R.D. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat. Neurosci. 1998, 1:290-295.
184. Subrizi A., Hiidenmaa H., Ilmarinen T., Nymark S., Dubruel P., Uusitalo H., Yliperttula M., Urtti A., Skottman H. Generation of hESC-derived retinal pigment epithelium on biopolymer coated polyimide membranes. Biomaterials 2012, 33:8047-8054.
185. Sun Y., Pollard S., Conti L., Toselli M., Biella G., Parkin G., Willatt L., Falk A., Cattaneo E., Smith A. Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture. Mol. Cell. Neurosci. 2008, 38:245-258.
186. Sundberg M., Bogetofte H., Lawson T., Jansson J., Smith G., Astradsson A., Moore M., Osborn T., Cooper O., Spealman R., et al. Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons. Stem Cells 2013, 31:1548-1562.
187. Tabar V., Studer L. Pluripotent stem cells in regenerative medicine: challenges and recent progress. Nat. Rev. Genet. 2014, 15:82-92.
188. Tabar V., Panagiotakos G., Greenberg E.D., Chan B.K., Sadelain M., Gutin P.H., Studer L. Migration and differentiation of neural precursors derived from human embryonic stem cells in the rat brain. Nat. Biotechnol. 2005, 23:601-606.
189. Tachibana M., Amato P., Sparman M., Gutierrez N.M., Tippner-Hedges R., Ma H., Kang E., Fulati A., Lee H.S., Sritanaudomchai H., et al. Human embryonic stem cells derived by somatic cell nuclear transfer. Cell 2013, 153:1228-1238.
190. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
191. Tamaki S.J., Jacobs Y., Dohse M., Capela A., Cooper J.D., Reitsma M., He D., Tushinski R., Belichenko P.V., Salehi A., et al. Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis. Cell Stem Cell 2009, 5:310-319.
192. Tannenbaum S.E., Turetsky T.T., Singer O., Aizenman E., Kirshberg S., Ilouz N., Gil Y., Berman-Zaken Y., Perlman T.S., Geva N., et al. Derivation of xeno-free and GMP-grade human embryonic stem cells-platforms for future clinical applications. PLoS ONE 2012, 7:e35325.
193. Thestrup T., Litzlbauer J., Bartholomäus I., Mues M., Russo L., Dana H., Kovalchuk Y., Liang Y., Kalamakis G., Laukat Y., et al. Optimized ratiometric calcium sensors for functional invivo imaging of neurons and T lymphocytes. Nat. Methods 2014, 11:175-182.
194. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
195. Thu M.S., Bryant L.H., Coppola T., Jordan E.K., Budde M.D., Lewis B.K., Chaudhry A., Ren J., Varma N.R., Arbab A.S., Frank J.A. Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. Nat. Med. 2012, 18:463-467.
196. Tornero D., Wattananit S., Gronning Madsen M., Koch P., Wood J., Tatarishvili J., Mine Y., Ge R., Monni E., Devaraju K., et al. Human induced pluripotent stem cell-derived cortical neurons integrate in stroke-injured cortex and improve functional recovery. Brain 2013, 136:3561-3577.
197. Tsukamoto A., Uchida N., Capela A., Gorba T., Huhn S. Clinical translation of human neural stem cells. Stem Cell Res. Ther. 2013, 4:102.
198. Turner M., Leslie S., Martin N.G., Peschanski M., Rao M., Taylor C.J., Trounson A., Turner D., Yamanaka S., Wilmut I. Toward the development of a global induced pluripotent stem cell library. Cell Stem Cell 2013, 13:382-384.
199. Uccelli A., Laroni A., Freedman M.S. Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases. Lancet Neurol. 2011, 10:649-656.
200. Uchida N., Buck D.W., He D., Reitsma M.J., Masek M., Phan T.V., Tsukamoto A.S., Gage F.H., Weissman I.L. Direct isolation of human central nervous system stem cells. Proc. Natl. Acad. Sci. USA 2000, 97:14720-14725.
201. Uchida N., Chen K., Dohse M., Hansen K.D., Dean J., Buser J.R., Riddle A., Beardsley D.J., Wan Y., Gong X., et al. Human neural stem cells induce functional myelination in mice with severe dysmyelination. Sci. Transl. Med. 2012, 4:155ra136.
202. van de Leemput J., Boles N.C., Kiehl T.R., Corneo B., Lederman P., Menon V., Lee C., Martinez R.A., Levi B.P., Thompson C.L., et al. CORTECON: a temporal transcriptome analysis of invitro human cerebral cortex development from human embryonic stem cells. Neuron 2014, 83:51-68.
203. Vazin T., Chen J., Lee C.T., Amable R., Freed W.J. Assessment of stromal-derived inducing activity in the generation of dopaminergic neurons from human embryonic stem cells. Stem Cells 2008, 26:1517-1525.
204. Vierbuchen T., Ostermeier A., Pang Z.P., Kokubu Y., Südhof T.C., Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463:1035-1041.
205. Vugler A., Carr A.J., Lawrence J., Chen L.L., Burrell K., Wright A., Lundh P., Semo M., Ahmado A., Gias C., et al. Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation. Exp. Neurol. 2008, 214:347-361.
206. Wahl A.S., Omlor W., Rubio J.C., Chen J.L., Zheng H., Schröter A., Gullo M., Weinmann O., Kobayashi K., Helmchen F., et al. Neuronal repair. Asynchronous therapy restores motor control by rewiring of the rat corticospinal tract after stroke. Science 2014, 344:1250-1255.
207. Walton N.M., Sutter B.M., Chen H.X., Chang L.J., Roper S.N., Scheffler B., Steindler D.A. Derivation and large-scale expansion of multipotent astroglial neural progenitors from adult human brain. Development 2006, 133:3671-3681.
208. Wan H., Li F., Zhu L., Wang J., Yang Z., Pan Y. Update on therapeutic mechanism for bone marrow stromal cells in ischemic stroke. J.Mol. Neurosci. 2014, 52:177-185.
209. Wang S., Bates J., Li X., Schanz S., Chandler-Militello D., Levine C., Maherali N., Studer L., Hochedlinger K., Windrem M., Goldman S.A. Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell 2013, 12:252-264.
210. Weick J.P., Johnson M.A., Skroch S.P., Williams J.C., Deisseroth K., Zhang S.C. Functional control of transplantable human ESC-derived neurons via optogenetic targeting. Stem Cells 2010, 28:2008-2016.
211. Weick J.P., Liu Y., Zhang S.C. Human embryonic stem cell-derived neurons adopt and regulate the activity of an established neural network. Proc. Natl. Acad. Sci. USA 2011, 108:20189-20194.
212. Wenning G.K., Odin P., Morrish P., Rehncrona S., Widner H., Brundin P., Rothwell J.C., Brown R., Gustavii B., Hagell P., et al. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann. Neurol. 1997, 42:95-107.
213. Wietek J., Wiegert J.S., Adeishvili N., Schneider F., Watanabe H., Tsunoda S.P., Vogt A., Elstner M., Oertner T.G., Hegemann P. Conversion of channelrhodopsin into a light-gated chloride channel. Science 2014, 344:409-412.
214. Xi J., Liu Y., Liu H., Chen H., Emborg M.E., Zhang S.C. Specification of midbrain dopamine neurons from primate pluripotent stem cells. Stem Cells 2012, 30:1655-1663.
215. Xu L., Shen P., Hazel T., Johe K., Koliatsos V.E. Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats. Neurosci. Lett. 2011, 494:222-226.
216. Yamada M., Johannesson B., Sagi I., Burnett L.C., Kort D.H., Prosser R.W., Paull D., Nestor M.W., Freeby M., Greenberg E., et al. Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells. Nature 2014, 510:533-536.
217. Yan Y., Yang D., Zarnowska E.D., Du Z., Werbel B., Valliere C., Pearce R.A., Thomson J.A., Zhang S.C. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 2005, 23:781-790.
218. Yan J., Xu L., Welsh A.M., Hatfield G., Hazel T., Johe K., Koliatsos V.E. Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord. PLoS Med. 2007, 4:e39.
219. Yoo A.S., Sun A.X., Li L., Shcheglovitov A., Portmann T., Li Y., Lee-Messer C., Dolmetsch R.E., Tsien R.W., Crabtree G.R. MicroRNA-mediated conversion of human fibroblasts to neurons. Nature 2011, 476:228-231.
220. Yu D.X., Di Giorgio F.P., Yao J., Marchetto M.C., Brennand K., Wright R., Mei A., McHenry L., Lisuk D., Grasmick J.M., et al. Modeling hippocampal neurogenesis using human pluripotent stem cells. Stem Cell Reports 2014, 2:295-310.
221. Zhang S.C., Wernig M., Duncan I.D., Brüstle O., Thomson J.A. Invitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat. Biotechnol. 2001, 19:1129-1133.
222. Zhang F., Vierock J., Yizhar O., Fenno L.E., Tsunoda S., Kianianmomeni A., Prigge M., Berndt A., Cushman J., Polle J., et al. The microbial opsin family of optogenetic tools. Cell 2011, 147:1446-1457.
223. Zhang Y., Pak C., Han Y., Ahlenius H., Zhang Z., Chanda S., Marro S., Patzke C., Acuna C., Covy J., et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 2013, 78:785-798.
224. Zhao R.R., Andrews M.R., Wang D., Warren P., Gullo M., Schnell L., Schwab M.E., Fawcett J.W. Combination treatment with anti-Nogo-A and chondroitinase ABC is more effective than single treatments at enhancing functional recovery after spinal cord injury. Eur. J. Neurosci. 2013, 38:2946-2961.
225. Zhu Y., Carido M., Meinhardt A., Kurth T., Karl M.O., Ader M., Tanaka E.M. Three-dimensional neuroepithelial culture from human embryonic stem cells and its use for quantitative conversion to retinal pigment epithelium. PLoS ONE 2013, 8:e54552.